EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain
Abstract
Authors
S Moreno Guillén A Rivero P Ventayol V Falcó M Torralba M Schroeder V Neches LA Vallejo-Aparicio I Mackenzie M Turner C Harrison